ALKS

Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors

Retrieved on: 
Thursday, March 7, 2024

DUBLIN, March 7, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the appointment of a new independent director, Nancy S. Lurker, to the company's Board of Directors (the Board).

Key Points: 
  • DUBLIN, March 7, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the appointment of a new independent director, Nancy S. Lurker, to the company's Board of Directors (the Board).
  • "Nancy brings to the Board deep biopharmaceutical industry experience spanning executive leadership, governance, strategic planning, product development and commercialization.
  • "Nancy's appointment reflects the Board's ongoing commitment to robust board refreshment and diversity and to the importance of aligning the qualifications and experience of our directors with our strategy and growth opportunities.
  • We welcome Nancy to the Board and look forward to working together."

Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors

Retrieved on: 
Thursday, March 7, 2024

DUBLIN, March 7, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the appointment of a new independent director, Nancy S. Lurker, to the company's Board of Directors (the Board).

Key Points: 
  • DUBLIN, March 7, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the appointment of a new independent director, Nancy S. Lurker, to the company's Board of Directors (the Board).
  • "Nancy brings to the Board deep biopharmaceutical industry experience spanning executive leadership, governance, strategic planning, product development and commercialization.
  • "Nancy's appointment reflects the Board's ongoing commitment to robust board refreshment and diversity and to the importance of aligning the qualifications and experience of our directors with our strategy and growth opportunities.
  • We welcome Nancy to the Board and look forward to working together."

Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 15, 2024

Retrieved on: 
Thursday, February 8, 2024

DUBLIN, Feb. 8, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m.

Key Points: 
  • DUBLIN, Feb. 8, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m.
  • ET (1:00 p.m. GMT) on Thursday, Feb. 15, 2024 to discuss the company's fourth quarter and year-end 2023 financial results.
  • Management will also discuss financial expectations for 2024 and provide an update on the company.
  • The webcast player and accompanying slides may be accessed on the Investors section of Alkermes' website at www.alkermes.com .

Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 15, 2024

Retrieved on: 
Thursday, February 8, 2024

DUBLIN, Feb. 8, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m.

Key Points: 
  • DUBLIN, Feb. 8, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m.
  • ET (1:00 p.m. GMT) on Thursday, Feb. 15, 2024 to discuss the company's fourth quarter and year-end 2023 financial results.
  • Management will also discuss financial expectations for 2024 and provide an update on the company.
  • The webcast player and accompanying slides may be accessed on the Investors section of Alkermes' website at www.alkermes.com .

Alkermes to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Wednesday, January 3, 2024

DUBLIN, Jan. 3, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops, will provide a corporate overview and update at the 42nd Annual J.P. Morgan Healthcare Conference.

Key Points: 
  • DUBLIN, Jan. 3, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops, will provide a corporate overview and update at the 42nd Annual J.P. Morgan Healthcare Conference.
  • The presentation will take place on Wednesday, Jan. 10, 2024 at 11:15 a.m. PST (2:15 p.m. EST/7:15 p.m. GMT), followed by a question and answer session.
  • The live webcast may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

Alkermes to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Wednesday, January 3, 2024

DUBLIN, Jan. 3, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops, will provide a corporate overview and update at the 42nd Annual J.P. Morgan Healthcare Conference.

Key Points: 
  • DUBLIN, Jan. 3, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops, will provide a corporate overview and update at the 42nd Annual J.P. Morgan Healthcare Conference.
  • The presentation will take place on Wednesday, Jan. 10, 2024 at 11:15 a.m. PST (2:15 p.m. EST/7:15 p.m. GMT), followed by a question and answer session.
  • The live webcast may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

Alkermes to Participate in Two Upcoming Investor Conferences

Retrieved on: 
Tuesday, November 21, 2023

DUBLIN, Nov. 21, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in fireside chat presentations at two upcoming investor conferences.

Key Points: 

DUBLIN, Nov. 21, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in fireside chat presentations at two upcoming investor conferences.
The live webcasts may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

Alkermes to Participate in Two Upcoming Investor Conferences

Retrieved on: 
Tuesday, November 21, 2023

DUBLIN, Nov. 21, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in fireside chat presentations at two upcoming investor conferences.

Key Points: 

DUBLIN, Nov. 21, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in fireside chat presentations at two upcoming investor conferences.
The live webcasts may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

Alkermes to Participate in the Jefferies London Healthcare Conference

Retrieved on: 
Tuesday, November 7, 2023

DUBLIN, Nov. 7, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Jefferies London Healthcare Conference on Tuesday, Nov. 14, 2023 at 12:00 p.m.

Key Points: 
  • DUBLIN, Nov. 7, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Jefferies London Healthcare Conference on Tuesday, Nov. 14, 2023 at 12:00 p.m.
  • ET (5:00 p.m. GMT).
  • The live webcast may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

Alkermes to Participate in the Jefferies London Healthcare Conference

Retrieved on: 
Tuesday, November 7, 2023

DUBLIN, Nov. 7, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Jefferies London Healthcare Conference on Tuesday, Nov. 14, 2023 at 12:00 p.m.

Key Points: 
  • DUBLIN, Nov. 7, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Jefferies London Healthcare Conference on Tuesday, Nov. 14, 2023 at 12:00 p.m.
  • ET (5:00 p.m. GMT).
  • The live webcast may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.